Domestic price of ponatinib

Ponatinib (Ponatinib) is used to treat certain types of chronic myelogenous leukemia (a cancer of the CML white blood cells), including in people who no longer benefit from other CML drugs or who can't take them because of side effects. Ponatinib is also used to treat people with certain types of acute lymphoblastic leukemia (ALL, a cancer of the white blood cells) who no longer benefit from other leukemia drugs or who cannot take them because of side effects.

Ponatinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells, which helps prevent the spread of cancer cells. The starting dose of ponatinib treatment is 45 mg orally once daily. If there is no hematological response within 3 months, consider discontinuing ponatinib. If adverse reactions occur, your doctor may delay treatment, adjust the dose, or permanently stop ponatinib.

The original drug of Ponatinib has not yet been launched in China, so it is not included in the medical insurance. Domestic patients in need may only purchase it through overseas channels. The Hong Kong original version of Ponatinib specificationsThe price of 45mg*30 tablets per box may be around 40,000 yuan (the price may fluctuate due to the exchange rate), which is expensive. There are also generic ponatinib drugs produced in other countries, which are relatively cheap. The price of 45mg*30 tablets per box produced by Everest Pharmaceutical Factory in Bangladesh may be around 4,000 yuan (the price may fluctuate due to the exchange rate). Its drug ingredients are basically the same as those of the original drug. For more drug information and specific prices, please consult the medical consultant of Yaode.